在绝经后的骨质疏松症中,雌激醇通过ST3Gal1调节骨质细胞化
Ce Dou1, Yang Dan2, Ziyang Zhang1
1Department of Orthopedics, Southwest Hospital, Army Medical University, Chongqing, China.
Bone research
|February 12, 2026
概括
绝经后的雌激素损失通过激活骨质细胞中的FOS-ST3GAL1化通路来加速骨质损失. 在雌激素缺乏的模型中,利达治疗逆转了骨质损失,这表明骨质疏松症的治疗标.
科学领域:
- 生物化学 生化学
- 细胞生物学 细胞生物学
- 内分泌学 在内分泌学.
背景情况:
- 绝经后的雌激素缺乏会通过增加骨质细胞活性来加速骨质损失.
- 链接雌激素信号与骨质细胞调节的分子机制尚未完全理解.
研究的目的:
- 为了确定调解RANKL诱导的骨质结晶发生在绝经后骨损失的分子途径.
- 为了研究基转移酶ST3GAL-I在雌激素缺陷骨质疏松症中的作用.
主要方法:
- 研究了雌激素受体α (ERα),TRAF6和c-FOS在调节ST3GAL1转录中的相互作用.
- 分析了血清酸水平,并对人类骨样本进行了单细胞RNA测序.
- 在雌激素缺乏的小鼠模型中进行了在体内实验,使用西阿利达斯治疗.
主要成果:
- 确定了ST3GAL-I作为RANKL诱导的骨质细胞形成的关键调解者.
- 与雌激素结合的ERα抑制了c-FOS依赖的ST3GAL1诱导.
- 在绝经后患有骨质疏松症的妇女中观察到血清酸和ST3GAL1表达在骨质细胞中的增加.
- 在雌激素缺乏模型中,利达治疗减少了骨损失.
结论:
- 确定了雌激素损失与骨质细胞中FOS-ST3GAL1化通路的激活之间的直接联系.
- 这一途径提供了对绝经后骨质疏松症的机械洞察力.
- 准这种途径可能为骨质疏松症提供一种新的治疗策略.
更多相关视频
08:53Drug Treatment and In Vivo Imaging of Osteoblast-Osteoclast Interactions in a Medaka Fish Osteoporosis Model
Published on: January 1, 2017
9.8K
09:37A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation
Published on: March 15, 2018
14.5K
相关概念视频
Osteoclasts in Bone Remodeling
4.3K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
4.3K
Epigenetic Regulation
33.9K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
33.9K
GTPases and their Regulation
9.9K
Guanine nucleotide-binding proteins (G-proteins), also known as GTPases, are a superfamily of proteins that regulate many cellular processes, such as cell signaling, vesicular transport, and the regulation of cell shape and motility. Mutation or dysfunction of these proteins can lead to disease. There are around 40,000 known G-proteins that can broadly be classified into two groups ‒ small G-proteins consisting of a single domain and large multi-domain G-proteins.
Large G-proteins,...
Large G-proteins,...
9.9K
Regulated Protein Degradation
8.9K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
8.9K
Master Transcription Regulators
7.8K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.8K
Negative Regulator Molecules
38.6K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.6K
